A.P.M. van der Meijden

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales et al. · The Journal of Urology · 1992 · 795 citations

Medicine, Oncology, Urology +8

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, P. A. Steerenberg et al. · Cancer Immunology Immunotherapy · 1992 · 201 citations · Full text

Medicine, Immunology, Urology +14

Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the Bladder

P. D. J. Vegt, J. Alfred Witjes, Wim P.J. Witjes et al. · The Journal of Urology · 1995 · 124 citations

Medicine, Oncology, Urology +13

One Immediate Postoperative Instillation of Chemotherapy in Low Risk Ta, T1 Bladder Cancer Patients. Is it Always Safe?

Jorg R. Oddens, A.P.M. van der Meijden, Richard Sylvester · European Urology · 2004 · 123 citations

Medicine, Surgery, Urology +9

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin

Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden et al. · Cancer Immunology Immunotherapy · 1991 · 112 citations · Full text

Medicine, Immunology, Oncology +12